Adult Brain Tumor Imaging: State of the Art

被引：14

作者：

Bangiyev, Lev ^{[1
]}

Espagnet, Maria Camilla Rossi ^{[1
]}

Young, Robert ^{[2
]}

Shepherd, Timothy ^{[1
]}

Knopp, Edmond ^{[3
]}

Friedman, Kent ^{[1
]}

Boada, Fernando ^{[1
]}

Fatterpekar, Girish M. ^{[1
]}

机构：

[1] NYU, Dept Radiol, Langone Med Ctr, New York, NY 10016 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA

[3] Zwanger Pesiri Radiol, Dept Radiol, Lindenhurst, NY USA

来源：

SEMINARS IN ROENTGENOLOGY | 2014年 / 49卷 / 01期

关键词：

CEREBRAL BLOOD-VOLUME; HIGH-GRADE GLIOMAS; APPARENT DIFFUSION-COEFFICIENT; PHASE-II; PERFUSION; DIFFERENTIATION; PERMEABILITY; SPECTROSCOPY; PROGRESSION; RECURRENCE;

D O I：

10.1053/j.ro.2013.11.001

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

[No abstract available]

引用

页码：39 / 52

页数：14

共 39 条

[1] Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma [J].

Aghi, M ;

Gaviani, P ;

Henson, JW ;

Batchelor, TT ;

Louis, DN ;

Barker, FG .

CLINICAL CANCER RESEARCH, 2005, 11 (24) :8600-8605

[2] Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease? [J].

Bisdas, S. ;

Kirkpatrick, M. ;

Giglio, P. ;

Welsh, C. ;

Spampinato, M. V. ;

Rumboldt, Z. .

AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (04) :681-688

[3]

Cha S, 2006, AM J NEURORADIOL, V27, P409

[4] Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging [J].

Cha, S ;

Knopp, EA ;

Johnson, G ;

Wetzel, SG ;

Litt, AW ;

Zagzag, D .

RADIOLOGY, 2002, 223 (01) :11-29

[5] MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis [J].

Chen, Yang ;

Hu, Fulan ;

Zhou, Yiheng ;

Chen, Wangyang ;

Shao, Hongying ;

Zhang, Ying .

ARCHIVES OF MEDICAL RESEARCH, 2013, 44 (04) :281-290

[6] A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM) [J].

Cloughesy, T. F. ;

Prados, M. D. ;

Wen, P. Y. ;

Mikkelsen, T. ;

Abrey, L. E. ;

Schiff, D. ;

Yung, W. K. ;

Maoxia, Z. ;

Dimery, I. ;

Friedman, H. S. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[7] Dynamic magnetic resonance perfusion imaging of brain tumors [J].

Covarrubias, DJ ;

Rosen, BR ;

Lev, MH .

ONCOLOGIST, 2004, 9 (05) :528-537

[8] Treatment-Related Change Versus Tumor Recurrence in High-Grade Gliomas: A Diagnostic Conundrum-Use of Dynamic Susceptibility Contrast-Enhanced (DSC) Perfusion MRI [J].

Fatterpekar, Girish M. ;

Galheigo, Diogo ;

Narayana, Ashwatha ;

Johnson, Glyn ;

Knopp, Edmond .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (01) :19-26

[9]

Henry RG, 2000, AM J NEURORADIOL, V21, P357

[10] Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements [J].

Hu, L. S. ;

Baxter, L. C. ;

Smith, K. A. ;

Feuerstein, B. G. ;

Karis, J. P. ;

Eschlbacher, J. M. ;

Coons, S. W. ;

Nakaji, P. ;

Yeh, R. F. ;

Debbins, J. ;

Heiserman, J. E. .

AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (03) :552-558

← 1 2 3 4 →